Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CASP6 | P55212 | 1/20 | 0.35 |
| ▸ | ELAVL1 | Q15717 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.34 |
| ▸ | MPL | P40238 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1180196 | 0.89 | GAA (0.41) | GAAHSD17B10AMY1AALDH1A1POLB | |
| SCHEMBL30823619 | 0.89 | GAA (0.41) | GAAHSD17B10AMY1AALDH1A1POLB | |
| SCHEMBL10817238 | 0.89 | GAA (0.35) | GAAHSD17B10AMY1AGSK3BALDH1A1 | |
| SCHEMBL29975298 | 0.86 | GAA (0.39) | GAAHSD17B10AMY1AALDH1A1POLB | |
| SCHEMBL30723203 | 0.86 | GAA (0.39) | GAAHSD17B10AMY1AALDH1A1POLB | |
| SCHEMBL5718625 | 0.86 | GAA (0.39) | GAAHSD17B10AMY1AALDH1A1POLB | |
| SCHEMBL816601 | 0.86 | GAA (0.39) | GAAHSD17B10AMY1AALDH1A1POLB | |
| SCHEMBL30716894 | 0.85 | AMY1A (0.44) | GAAHSD17B10AMY1AALDH1A1POLB | |
| SCHEMBL14991279 | 0.85 | AMY1A (0.44) | GAAHSD17B10AMY1AALDH1A1POLB | |
| SCHEMBL8084853 | 0.84 | GAA (0.38) | GAAHSD17B10AMY1AALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674839-A1 | NOVEL INDOLINE DERIVATIVE AND USE THEREOF | CK Regeon Inc. (KR) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024181799-A1 | NOVEL INDOLINE DERIVATIVE AND USE THEREOF | 주식회사 씨케이리제온 | 2024-09-06 | — | — | WO | disclosed |
| CN-118284597-A | Substituted indole compounds and uses thereof | 特罗彼奥治疗私人有限公司 | 2024-07-02 | — | — | CN | disclosed |
| EP-3169666-B1 | SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES | GRUENENTHAL GMBH (DE) | 2018-06-06 | — | — | EP | disclosed |
| US-20170210734-A1 | Substituted Azaspiro(4.5)Decane Derivatives | GRUENENTHAL GMBH (DE) | 2017-07-27 | — | — | US | disclosed |
| EP-3169666-A1 | SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES | Grünenthal GmbH (DE) | 2017-05-24 | — | — | EP | disclosed |
| WO-2016008582-A1 | SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES | Grünenthal GmbH (DE) | 2016-01-21 | — | — | WO | disclosed |
| WO-2014098593-A9 | VERAPAMIL LIKE COMPOUNDS | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 2014-10-23 | — | — | WO | disclosed |
| WO-2014098593-A1 | VERAPAMIL LIKE COMPOUNDS | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 2014-06-26 | — | — | WO | disclosed |
| US-20130137625-A1 | Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof | SOLARBRE, INC. (US) | 2013-05-30 | — | — | US | disclosed |
| US-8246869-B2 | Photo-responsive microencapsulation materials, compositions and methods of use thereof | SOLARBRE, INC. (US) | 2012-08-21 | — | — | US | disclosed |
| US-20090202652-A1 | Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof | SOLARBRE, INC. (US) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202652-A1 | Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof | LIPA, LIPE, CRYAA | GAA 134/4885HSD17B10 3865/4885AMY1A 1235/4885 |
| US-20170210734-A1 | Substituted Azaspiro(4.5)Decane Derivatives | OPRL1, OPRM1, OPRD1 | GAA 4141/4885HSD17B10 3382/4885AMY1A 4478/4885 |
| US-20130137625-A1 | Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof | LIPA, LIPE, CRYAA | GAA 134/4885HSD17B10 3865/4885AMY1A 1235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.